Core Viewpoint - The company is currently experiencing losses primarily due to market adjustments and government procurement impacts on its vaccine and IVD segments [1] Group 1 - The company aims to continuously improve management levels to enhance business scale and efficiency [1] - The company plans to promote sustainable development and create greater value for shareholders through both organic growth and external expansion [1] - The company is committed to providing better returns for investors [1]